Symbols / COSM
COSM Chart
About
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Distribution | Market Cap | 13.59M |
| Enterprise Value | 32.85M | Income | -18.54M | Sales | 59.79M |
| Book/sh | 0.73 | Cash/sh | 0.03 | Dividend Yield | — |
| Payout | 0.00% | Employees | 149 | IPO | — |
| P/E | — | Forward P/E | -3.31 | PEG | — |
| P/S | 0.23 | P/B | 0.50 | P/C | — |
| EV/EBITDA | -2.60 | EV/Sales | 0.55 | Quick Ratio | 0.55 |
| Current Ratio | 0.99 | Debt/Eq | 91.08 | LT Debt/Eq | — |
| EPS (ttm) | -0.77 | EPS next Y | -0.11 | EPS Growth | — |
| Revenue Growth | 37.90% | Earnings | 2025-11-14 16:00 | ROA | -13.03% |
| ROE | -63.82% | ROIC | — | Gross Margin | 11.41% |
| Oper. Margin | -10.63% | Profit Margin | -31.01% | Shs Outstand | 37.35M |
| Shs Float | 23.71M | Short Float | 0.35% | Short Ratio | 0.08 |
| Short Interest | — | 52W High | 1.32 | 52W Low | 0.28 |
| Beta | 4.47 | Avg Volume | 901.47K | Volume | 650.76K |
| Target Price | $4.50 | Recom | None | Prev Close | $0.38 |
| Price | $0.36 | Change | -3.42% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$4.50
Mean price target
2. Current target
$0.36
Latest analyst target
3. DCF / Fair value
$-2.56
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.36
Low
$4.50
High
$4.50
Mean
$4.50
- Cosmos Health says its buildings are worth more than its stock - Stock Titan hu, 19 Feb 2026 16
- $COSM stock is up 16% today. Here's what we see in our data. - Quiver Quantitative hu, 15 Jan 2026 08
- Investors Give Cosmos Health Inc. (NASDAQ:COSM) Shares A 27% Hiding - simplywall.st Sun, 15 Feb 2026 08
- Insiders Who Purchased US$2.38m Of Cosmos Health Stock May Not Have Expected 15% Tumble - Yahoo Finance Sun, 15 Feb 2026 08
- Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value - GlobeNewswire hu, 19 Feb 2026 16
- Siokas, Cosmos Health CEO, buys $40k in COSM stock - Investing.com hu, 20 Nov 2025 08
- StockWatch: Cosmo Surges 40% on Baldness Candidate’s Phase III Data - GEN - Genetic Engineering and Biotechnology News Sun, 07 Dec 2025 08
- Why a healthcare group is betting $500,000 on Bitcoin after a sell-off - Stock Titan Wed, 11 Feb 2026 08
- Cosmos Health Inc. CEO Greg Siokas Increases Share Ownership Amid Record Q3 Results - Quiver Quantitative ue, 02 Dec 2025 08
- Cosmos Health CEO Siokas buys $32,000 in COSM stock - Investing.com Fri, 21 Nov 2025 08
- Antimicrobial C-Scrub wash joins Superdrug, the UK’s second-largest beauty and health retailer - Stock Titan Wed, 18 Feb 2026 18
- Tesco adds antimicrobial C-Scrub skin wash from Cosmos Health - Stock Titan Wed, 18 Feb 2026 15
- AI research, crypto and $4.50 call put small-cap Cosmos Health on radar - Stock Titan Wed, 14 Jan 2026 08
- Cosmos Health (NASDAQ: COSM) partners with Prime Ledger to tokenize IP, manage $300M - Stock Titan Wed, 03 Dec 2025 08
- Greek drug distributor adds 100 pharmacies, builds robots for $40M potential - Stock Titan ue, 20 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 388532 | 145000 | — | Purchase at price 0.37 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-02-12 00:00:00 | D |
| 1 | 291262 | 120000 | — | Purchase at price 0.41 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-02-11 00:00:00 | D |
| 2 | 90325 | 45000 | — | Purchase at price 0.50 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-23 00:00:00 | D |
| 3 | 353321 | 175000 | — | Purchase at price 0.50 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-20 00:00:00 | D |
| 4 | 493495 | 220000 | — | Purchase at price 0.45 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-14 00:00:00 | D |
| 5 | 113185 | 57000 | — | Purchase at price 0.50 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-12 00:00:00 | D |
| 6 | 156190 | 81000 | — | Purchase at price 0.52 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-08 00:00:00 | D |
| 7 | 124880 | 65000 | — | Purchase at price 0.52 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-07 00:00:00 | D |
| 8 | 133953 | 72000 | — | Purchase at price 0.54 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-06 00:00:00 | D |
| 9 | 88314 | 43000 | — | Purchase at price 0.49 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2025-12-19 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 125.90K | 74.21K |
| TaxRateForCalcs | 0.00 | 0.00 | 0.22 | 0.24 |
| NormalizedEBITDA | -13.51M | -20.62M | -9.47M | -4.13M |
| TotalUnusualItems | -411.04K | 3.56M | 572.26K | 309.19K |
| TotalUnusualItemsExcludingGoodwill | -411.04K | 3.56M | 572.26K | 309.19K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -16.18M | -18.54M | -13.83M | -7.96M |
| ReconciledDepreciation | 1.25M | 614.38K | 188.89K | 449.69K |
| ReconciledCostOfRevenue | 50.12M | 49.03M | 44.39M | 47.91M |
| EBITDA | -13.92M | -17.06M | -8.90M | -3.82M |
| EBIT | -15.17M | -17.68M | -9.09M | -4.27M |
| NetInterestIncome | -605.87K | -203.62K | -3.73M | -3.53M |
| InterestExpense | 1.01M | 866.48K | 3.97M | 3.58M |
| InterestIncome | 406.45K | 662.86K | 236.35K | 46.32K |
| NormalizedIncome | -15.77M | -22.10M | -14.28M | -8.20M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -16.18M | -18.54M | -13.83M | -7.96M |
| TotalExpenses | 69.68M | 75.21M | 57.82M | 60.77M |
| TotalOperatingIncomeAsReported | -15.54M | -21.83M | -7.47M | -4.53M |
| DilutedAverageShares | 19.15M | 11.97M | 1.93M | 656.93K |
| BasicAverageShares | 19.15M | 11.97M | 1.93M | 656.93K |
| DilutedEPS | -1.17 | -2.15 | -33.16 | -23.74 |
| BasicEPS | -1.17 | -2.15 | -33.16 | -23.74 |
| DilutedNIAvailtoComStockholders | -22.38M | -25.78M | -63.95M | -15.59M |
| NetIncomeCommonStockholders | -22.38M | -25.78M | -63.95M | -15.59M |
| OtherunderPreferredStockDividend | 6.20M | 7.24M | 41.55M | 7.63M |
| PreferredStockDividends | 8.56M | |||
| NetIncome | -16.18M | -18.54M | -13.83M | -7.96M |
| NetIncomeIncludingNoncontrollingInterests | -16.18M | -18.54M | -13.83M | -7.96M |
| NetIncomeContinuousOperations | -16.18M | -18.54M | -13.83M | -7.96M |
| TaxProvision | 0.00 | 0.00 | 775.05K | 114.01K |
| PretaxIncome | -16.18M | -18.54M | -13.06M | -7.85M |
| OtherIncomeExpense | -324.30K | 3.49M | -1.85M | 220.31K |
| OtherNonOperatingIncomeExpenses | 86.74K | -65.87K | -2.42M | -88.88K |
| SpecialIncomeCharges | -291.98K | 3.35M | 1.00M | 606.67K |
| OtherSpecialCharges | -1.91M | -1.00M | -606.67K | |
| ImpairmentOfCapitalAssets | 291.98K | 0.00 | ||
| RestructuringAndMergernAcquisition | 0.00 | -1.44M | 0.00 | |
| GainOnSaleOfSecurity | -119.06K | 206.83K | -431.86K | -297.47K |
| NetNonOperatingInterestIncomeExpense | -605.87K | -203.62K | -3.73M | -3.53M |
| InterestExpenseNonOperating | 1.01M | 866.48K | 3.97M | 3.58M |
| InterestIncomeNonOperating | 406.45K | 662.86K | 236.35K | 46.32K |
| OperatingIncome | -15.25M | -21.83M | -7.47M | -4.53M |
| OperatingExpense | 19.56M | 26.18M | 13.43M | 12.86M |
| DepreciationAmortizationDepletionIncomeStatement | 1.25M | 614.38K | 188.89K | 449.69K |
| DepreciationAndAmortizationInIncomeStatement | 1.25M | 614.38K | 188.89K | 449.69K |
| ResearchAndDevelopment | 533.29K | 164.86K | ||
| SellingGeneralAndAdministration | 17.78M | 25.40M | 13.24M | 12.41M |
| SellingAndMarketingExpense | 354.97K | 1.20M | 630.06K | 732.54K |
| GeneralAndAdministrativeExpense | 17.43M | 24.20M | 12.61M | 11.68M |
| OtherGandA | 11.73M | 19.64M | 10.18M | 9.21M |
| SalariesAndWages | 5.69M | 4.55M | 2.43M | 2.47M |
| GrossProfit | 4.31M | 4.35M | 5.96M | 8.33M |
| CostOfRevenue | 50.12M | 49.03M | 44.39M | 47.91M |
| TotalRevenue | 54.43M | 53.38M | 50.35M | 56.24M |
| OperatingRevenue | 54.43M | 53.38M | 50.35M | 56.24M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 86.50K | 86.50K | 15.50K | 15.50K |
| OrdinarySharesNumber | 23.60M | 15.90M | 10.59M | 686.28K |
| ShareIssued | 23.69M | 15.98M | 10.61M | 701.78K |
| NetDebt | 10.80M | 7.43M | 25.78M | |
| TotalDebt | 11.82M | 12.42M | 12.03M | 27.12M |
| TangibleBookValue | 16.78M | 28.24M | 38.58M | 3.89M |
| InvestedCapital | 35.64M | 47.30M | 50.18M | 30.45M |
| WorkingCapital | -296.19K | 12.29M | 34.62M | 9.90M |
| NetTangibleAssets | 16.78M | 28.24M | 38.95M | 3.89M |
| CapitalLeaseObligations | 710.00K | 1.16M | 1.12M | 1.06M |
| CommonStockEquity | 24.53M | 36.04M | 39.28M | 4.38M |
| PreferredStockEquity | 372.41K | |||
| TotalCapitalization | 26.09M | 39.08M | 42.52M | 17.10M |
| TotalEquityGrossMinorityInterest | 24.53M | 36.04M | 39.66M | 4.38M |
| StockholdersEquity | 24.53M | 36.04M | 39.66M | 4.38M |
| OtherEquityInterest | -20.00 | -20.00 | -4.75M | |
| GainsLossesNotAffectingRetainedEarnings | -2.13M | -419.84K | -1.13M | -151.62K |
| OtherEquityAdjustments | -2.13M | -419.84K | -1.13M | -151.62K |
| TreasuryStock | 917.16K | 917.16K | 816.71K | 816.71K |
| RetainedEarnings | -114.02M | -91.64M | -66.23M | -34.35M |
| AdditionalPaidInCapital | 141.58M | 129.01M | 112.21M | 39.69M |
| CapitalStock | 23.69K | 15.98K | 383.02K | 702.00 |
| CommonStock | 23.69K | 15.98K | 10.61K | 702.00 |
| PreferredStock | 0.00 | 0.00 | 372.41K | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 29.78M | 29.97M | 28.38M | 45.05M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 4.02M | 5.65M | 6.63M | 15.12M |
| OtherNonCurrentLiabilities | 1.96M | 1.76M | 2.91M | 1.55M |
| LongTermDebtAndCapitalLeaseObligation | 2.06M | 3.89M | 3.72M | 13.57M |
| LongTermCapitalLeaseObligation | 501.80K | 850.13K | 860.10K | 844.42K |
| LongTermDebt | 1.56M | 3.04M | 2.86M | 12.72M |
| CurrentLiabilities | 25.76M | 24.32M | 21.75M | 29.93M |
| OtherCurrentLiabilities | 3.35M | 3.47M | 2.70M | 1.30M |
| CurrentDebtAndCapitalLeaseObligation | 9.76M | 8.54M | 8.31M | 13.56M |
| CurrentCapitalLeaseObligation | 208.20K | 312.79K | 264.48K | 211.53K |
| CurrentDebt | 9.55M | 8.23M | 8.04M | 13.34M |
| OtherCurrentBorrowings | 2.55M | 1.58M | 2.27M | 8.18M |
| LineOfCredit | 6.99M | 6.63M | 5.76M | 4.70M |
| CurrentNotesPayable | 10.56K | 11.28K | 10.91K | 464.26K |
| PayablesAndAccruedExpenses | 12.65M | 12.31M | 10.74M | 15.07M |
| CurrentAccruedExpenses | 221.82K | 166.35K | 275.55K | 1.02M |
| InterestPayable | 221.82K | 166.35K | 275.55K | 1.02M |
| Payables | 12.43M | 12.14M | 10.47M | 14.05M |
| DuetoRelatedPartiesCurrent | 1.27M | 231.56K | 205.36K | 599.12K |
| TotalTaxPayable | 0.00 | 126.86K | 1.32M | |
| AccountsPayable | 11.16M | 11.91M | 10.13M | 12.13M |
| TotalAssets | 54.31M | 66.01M | 68.04M | 49.43M |
| TotalNonCurrentAssets | 28.85M | 29.41M | 11.67M | 9.60M |
| OtherNonCurrentAssets | 2.92M | 1.06M | 391.62K | 915.25K |
| NonCurrentDeferredAssets | 0.00 | 850.77K | ||
| NonCurrentDeferredTaxesAssets | 0.00 | 850.77K | ||
| NonCurrentNoteReceivables | 5.77M | 7.05M | 7.64M | 4.41M |
| GoodwillAndOtherIntangibleAssets | 7.76M | 7.81M | 706.91K | 485.77K |
| OtherIntangibleAssets | 7.71M | 7.76M | 657.22K | 436.07K |
| Goodwill | 49.70K | 49.70K | 49.70K | 49.70K |
| NetPPE | 12.40M | 13.49M | 2.93M | 2.93M |
| AccumulatedDepreciation | -1.28M | -957.25K | -877.82K | -934.47K |
| GrossPPE | 13.67M | 14.45M | 3.81M | 3.87M |
| Leases | 3.40K | 3.64K | 502.88K | 519.28K |
| ConstructionInProgress | 2.00M | 2.00M | 0.00 | |
| OtherProperties | 709.77K | 1.16M | 1.11M | 1.05M |
| MachineryFurnitureEquipment | 3.11M | 2.95M | 2.19M | 2.30M |
| BuildingsAndImprovements | 4.53M | 4.79M | 0.00 | 834.47K |
| LandAndImprovements | 3.32M | 3.55M | 0.00 | |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 25.46M | 36.61M | 56.37M | 39.83M |
| OtherCurrentAssets | 4.89M | 6.25M | 4.94M | 6.25M |
| PrepaidAssets | 6.26M | |||
| Inventory | 4.36M | 4.79M | 3.45M | 3.15M |
| Receivables | 15.88M | 21.71M | 27.21M | 30.14M |
| DuefromRelatedPartiesCurrent | 1.23M | 1.10M | 2.71M | 3.27M |
| LoansReceivable | 1.17M | 854.34K | 804.96K | 377.59K |
| AccountsReceivable | 13.48M | 19.76M | 23.69M | 26.49M |
| AllowanceForDoubtfulAccountsReceivable | -22.80M | -19.69M | -7.31M | -1.70M |
| GrossAccountsReceivable | 36.28M | 39.45M | 31.00M | 28.19M |
| CashCashEquivalentsAndShortTermInvestments | 336.25K | 3.85M | 20.76M | 297.95K |
| OtherShortTermInvestments | 21.15K | 20.07K | 14.88K | 11.47K |
| CashAndCashEquivalents | 315.11K | 3.83M | 20.75M | 286.49K |
| CashFinancial | 315.11K | 3.83M | 20.75M | 286.49K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -8.98M | -24.80M | -15.25M | -7.99M |
| RepurchaseOfCapitalStock | 0.00 | -100.45K | 0.00 | -376.86K |
| RepaymentOfDebt | -26.28M | -21.27M | -40.39M | -25.66M |
| IssuanceOfDebt | 26.83M | 21.25M | 26.53M | 33.05M |
| IssuanceOfCapitalStock | 649.04K | 10.00M | 41.28M | 250.00K |
| CapitalExpenditure | -1.27M | -9.17M | -383.07K | -890.52K |
| InterestPaidSupplementalData | 704.84K | 406.88K | 588.05K | 2.06M |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 315.11K | 3.83M | 20.75M | 286.49K |
| BeginningCashPosition | 3.83M | 20.75M | 286.49K | 628.39K |
| EffectOfExchangeRateChanges | -49.47K | -214.14K | 307.04K | 314.31K |
| ChangesInCash | -3.47M | -16.70M | 20.16M | -656.21K |
| FinancingCashFlow | 5.05M | 12.69M | 35.05M | 7.27M |
| CashFlowFromContinuingFinancingActivities | 5.05M | 12.69M | 35.05M | 7.27M |
| NetOtherFinancingCharges | -391.57K | -717.89K | -3.19M | |
| ProceedsFromStockOptionExercised | 4.24M | 3.53M | 10.83M | 0.00 |
| NetPreferredStockIssuance | 0.00 | 6.00M | 0.00 | |
| PreferredStockIssuance | 0.00 | 6.00M | 0.00 | |
| NetCommonStockIssuance | 649.04K | 9.90M | 35.28M | -126.86K |
| CommonStockPayments | 0.00 | -100.45K | 0.00 | -376.86K |
| CommonStockIssuance | 649.04K | 10.00M | 35.28M | 250.00K |
| NetIssuancePaymentsOfDebt | 548.24K | -21.41K | -13.86M | 7.39M |
| NetShortTermDebtIssuance | 809.83K | 660.61K | -1.24M | 8.41M |
| ShortTermDebtPayments | -25.15M | -19.53M | -27.29M | -24.05M |
| ShortTermDebtIssuance | 25.96M | 20.19M | 26.04M | 32.46M |
| NetLongTermDebtIssuance | -261.58K | -682.02K | -12.62M | -1.01M |
| LongTermDebtPayments | -1.13M | -1.74M | -13.10M | -1.60M |
| LongTermDebtIssuance | 865.60K | 1.06M | 487.10K | 591.50K |
| InvestingCashFlow | -798.27K | -13.76M | -21.50K | -826.82K |
| CashFlowFromContinuingInvestingActivities | -798.27K | -13.76M | -21.50K | -826.82K |
| NetOtherInvestingChanges | 468.97K | 638.00K | 351.47K | 63.70K |
| NetInvestmentPurchaseAndSale | 0.00 | -2.63K | 0.00 | |
| PurchaseOfInvestment | 0.00 | -2.63K | 0.00 | |
| NetBusinessPurchaseAndSale | 0.00 | -5.23M | 0.00 | |
| PurchaseOfBusiness | 0.00 | -5.23M | 0.00 | |
| NetIntangiblesPurchaseAndSale | -849.17K | -6.19M | -308.87K | -309.12K |
| PurchaseOfIntangibles | -849.17K | -6.19M | -308.87K | -309.12K |
| NetPPEPurchaseAndSale | -418.07K | -2.98M | -61.47K | -581.40K |
| SaleOfPPE | 0.00 | 12.74K | 0.00 | |
| PurchaseOfPPE | -418.07K | -2.98M | -74.21K | -581.40K |
| OperatingCashFlow | -7.72M | -15.64M | -14.87M | -7.10M |
| CashFlowFromContinuingOperatingActivities | -7.72M | -15.64M | -14.87M | -7.10M |
| ChangeInWorkingCapital | 159.68K | -7.90M | -8.69M | -6.30M |
| ChangeInOtherCurrentLiabilities | 177.96K | -1.96M | 806.81K | 649.54K |
| ChangeInOtherCurrentAssets | 0.00 | 23.29K | ||
| ChangeInPayablesAndAccruedExpense | 1.12M | 472.15K | -285.99K | 4.74M |
| ChangeInAccruedExpense | 69.07K | -115.67K | -913.28K | 292.39K |
| ChangeInInterestPayable | 69.07K | -115.67K | -913.28K | 292.39K |
| ChangeInPayable | 1.05M | 587.81K | 627.29K | 4.45M |
| ChangeInAccountPayable | 1.05M | 716.62K | 1.73M | 3.82M |
| ChangeInTaxPayable | 0.00 | -128.80K | -1.11M | 622.05K |
| ChangeInIncomeTaxPayable | 0.00 | -128.80K | -1.11M | 622.05K |
| ChangeInPrepaidAssets | -2.51M | -1.49M | -1.27M | -3.17M |
| ChangeInInventory | 146.45K | -890.90K | -485.47K | -89.58K |
| ChangeInReceivables | 1.23M | -4.03M | -7.46M | -8.46M |
| ChangesInAccountReceivables | 1.23M | -4.03M | -3.24M | -5.79M |
| OtherNonCashItems | 288.83K | -975.75K | 1.90M | 1.03M |
| StockBasedCompensation | 1.69M | 577.93K | 24.40K | 5.90M |
| UnrealizedGainLossOnInvestmentSecurities | -2.47K | -4.58K | -1.68K | -2.54K |
| AssetImpairmentCharge | 5.09M | 11.85M | 5.62M | 1.30M |
| DeferredTax | -11.84K | 656.98K | 780.10K | -714.11K |
| DeferredIncomeTax | -11.84K | 656.98K | 780.10K | -714.11K |
| DepreciationAmortizationDepletion | 1.25M | 614.38K | 188.89K | 449.69K |
| DepreciationAndAmortization | 1.25M | 614.38K | 188.89K | 449.69K |
| Depreciation | 1.25M | 614.38K | 188.89K | 449.69K |
| OperatingGainsLosses | -1.91M | -856.64K | -800.18K | |
| GainLossOnInvestmentSecurities | -3.38K | 20.26K | -193.51K | |
| NetIncomeFromContinuingOperations | -16.18M | -18.54M | -13.83M | -7.96M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for COSM
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|